[
  {
    "ts": null,
    "headline": "The U.S. Lost Its Perfect Credit Rating. Who Still Has It.",
    "summary": "The U.S. Lost Its Perfect Credit Rating. Who Still Has It.",
    "url": "https://finnhub.io/api/news?id=cb23e2c5b9265facadb29c263b298667cb1ccf8ccc46398319dea0615867cae2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747673580,
      "headline": "The U.S. Lost Its Perfect Credit Rating. Who Still Has It.",
      "id": 134611692,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "The U.S. Lost Its Perfect Credit Rating. Who Still Has It.",
      "url": "https://finnhub.io/api/news?id=cb23e2c5b9265facadb29c263b298667cb1ccf8ccc46398319dea0615867cae2"
    }
  },
  {
    "ts": null,
    "headline": "Bond Selloff Sends 30-Year Treasury Yield Above 5%. What to Do Now.",
    "summary": "Bond Selloff Sends 30-Year Treasury Yield Above 5%. What to Do Now.",
    "url": "https://finnhub.io/api/news?id=bd91f122ba860b7a2058d0370ead9ade228eae2455d247f0de1cffc02867cb2d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747671120,
      "headline": "Bond Selloff Sends 30-Year Treasury Yield Above 5%. What to Do Now.",
      "id": 134611693,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Bond Selloff Sends 30-Year Treasury Yield Above 5%. What to Do Now.",
      "url": "https://finnhub.io/api/news?id=bd91f122ba860b7a2058d0370ead9ade228eae2455d247f0de1cffc02867cb2d"
    }
  },
  {
    "ts": null,
    "headline": "Innovative Health awarded $147m in antitrust lawsuit against J&J’s Biosense Webster",
    "summary": "Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s reprocessed catheters.",
    "url": "https://finnhub.io/api/news?id=0d82ecbe965339a7291f0ee0646032d51fff721e63c7d0612a6000b722b46617",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747670998,
      "headline": "Innovative Health awarded $147m in antitrust lawsuit against J&J’s Biosense Webster",
      "id": 134601584,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s reprocessed catheters.",
      "url": "https://finnhub.io/api/news?id=0d82ecbe965339a7291f0ee0646032d51fff721e63c7d0612a6000b722b46617"
    }
  },
  {
    "ts": null,
    "headline": "Moody's U.S. Debt Downgrade: Stocks Poised To Benefit",
    "summary": "Discover why top-rated corporations like Microsoft and Apple outperform governments in creditworthiness. Click for companies showing stability and growth.",
    "url": "https://finnhub.io/api/news?id=c65e527b7b08cf1c59ef48737e706a5368e282964dbfa0f9e5506f3fc9e2ee29",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747668326,
      "headline": "Moody's U.S. Debt Downgrade: Stocks Poised To Benefit",
      "id": 134600598,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1355648174/image_1355648174.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Discover why top-rated corporations like Microsoft and Apple outperform governments in creditworthiness. Click for companies showing stability and growth.",
      "url": "https://finnhub.io/api/news?id=c65e527b7b08cf1c59ef48737e706a5368e282964dbfa0f9e5506f3fc9e2ee29"
    }
  },
  {
    "ts": null,
    "headline": "Intravascular lithotripsy: market competition and clinical potential",
    "summary": "Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants.",
    "url": "https://finnhub.io/api/news?id=3634fe5a9f6b5b26408d2fd289a1983707a8008106e42148318217569049f2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747660081,
      "headline": "Intravascular lithotripsy: market competition and clinical potential",
      "id": 134601585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants.",
      "url": "https://finnhub.io/api/news?id=3634fe5a9f6b5b26408d2fd289a1983707a8008106e42148318217569049f2f9"
    }
  },
  {
    "ts": null,
    "headline": "Genmab A/S: Transitioning From Royalty Model To Commercial-Stage Oncology",
    "summary": "Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for long-term investors.",
    "url": "https://finnhub.io/api/news?id=05aa8a7840eb5c9e7b8b4a0b27a438566e3fe935528a088d33341dc09ac70511",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747638225,
      "headline": "Genmab A/S: Transitioning From Royalty Model To Commercial-Stage Oncology",
      "id": 134576550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/927016002/image_927016002.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for long-term investors.",
      "url": "https://finnhub.io/api/news?id=05aa8a7840eb5c9e7b8b4a0b27a438566e3fe935528a088d33341dc09ac70511"
    }
  }
]